Get the Stockscreener App
3.12
0.34%
-0.0107
Eupraxia Pharmaceuticals Inc Stock (EPRX) Forecast
The Eupraxia Pharmaceuticals Inc (EPRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.4978, representing a -19.94% decrease from the current price of $3.12. The highest analyst price target is $2.7982, and the lowest is $2.1973.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EPRX Price Target
Average 2.2959
(-26.41% Downside)
Is Eupraxia Pharmaceuticals Inc (EPRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.03 | Neutral |
| STOCH(9,6) | 38.09 | Neutral |
| STOCHRSI(14) | 43.57 | Neutral |
| MACD(12,26) | 0.1309 | Buy |
| ADX(14) | 37.18 | Buy |
| William %R | -48.73 | Neutral |
| CCI(14) | 35.47 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.067
Buy
|
3.0044
Buy
|
| MA20 |
2.8567
Buy
|
2.9002
Buy
|
| MA50 |
2.6813
Buy
|
2.7532
Buy
|
| MA100 |
2.6498
Buy
|
2.7166
Buy
|
| MA200 |
2.0226
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, EPRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on EPRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.03 indicates that EPRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.09 indicates that EPRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 43.57 indicates that EPRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.18 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 35.47 indicates that EPRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term EPRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eupraxia Pharmaceuticals Inc financial reports and earnings history, Eupraxia Pharmaceuticals Inc (EPRX) stock could reach $0.6645 by 2030, $3.8729 by 2040 and $8.0725 by 2050. See the projected annual prices until 2050 of the Eupraxia Pharmaceuticals Inc stock below:
- Eupraxia Pharmaceuticals Inc (EPRX) is expected to reach an average price of $1.856 in 2035, with a high prediction of $1.792 and a low estimate of $1.802. This indicates an $-40.51% rise from the last recorded price of $3.12.
- Eupraxia Pharmaceuticals Inc (EPRX) stock is projected to chart a bullish course in 2040, with an average price target of $3.962, representing an $26.99% surge from its current level. The forecast ranges from a conservative $3.8829 to a sky-high $3.8729.
- Our analysts predict Eupraxia Pharmaceuticals Inc (EPRX) to jump 94.95% by 2045, soaring from $5.9638 to an average price of $6.0823, potentially reaching $5.9665. While $5.9638 is the low estimate, the potential upside is significant.
- Eupraxia Pharmaceuticals Inc (EPRX) stock is expected to climb by 2050, reaching an average of $8.0297, a $157.36% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.0725 and $8.0447, respectively, highlighting the market's uncertainty.
Eupraxia Pharmaceuticals Inc Stock (EPRX) Year by Year Forecast
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2024
Our forecast for EPRX stock price in 2024 now indicates an average price target of $2.6387 with a high forecast of $3.08 and a low forecast of $2.1973. The average prediction reflects an decrease of -15.43% from the last recorded price of $3.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $2.459 | $2.1973 | $2.7982 | -21.18% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2025
Eupraxia Pharmaceuticals Inc Stock (EPRX) is expected to reach an average price of $2.2555 in 2025, with a high prediction of $2.7579 and a low estimate of $1.7532. This indicates an -27.71% fall from the last recorded price of $3.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.4189 | $2.157 | $2.7579 | -22.47% |
| February, 2025 | $2.4376 | $2.1166 | $2.7177 | -21.87% |
| March, 2025 | $2.2762 | $2.0762 | $2.4638 | -27.04% |
| April, 2025 | $2.2358 | $2.0358 | $2.6774 | -28.34% |
| May, 2025 | $2.2345 | $2.164 | $2.6372 | -28.38% |
| June, 2025 | $2.2962 | $1.9954 | $2.5969 | -26.40% |
| July, 2025 | $2.2559 | $1.9551 | $2.5566 | -27.70% |
| August, 2025 | $2.1781 | $1.9147 | $2.5164 | -30.19% |
| September, 2025 | $2.196 | $1.8743 | $2.4761 | -29.61% |
| October, 2025 | $2.1558 | $1.8339 | $2.4359 | -30.91% |
| November, 2025 | $1.9935 | $1.7935 | $2.1828 | -36.10% |
| December, 2025 | $1.9532 | $1.7532 | $2.3956 | -37.40% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2026
The predicted value for Eupraxia Pharmaceuticals Inc (EPRX) in 2026 is set at an average of $1.8524. Estimates vary from a peak of $2.3553 to a trough of $1.3494, indicating an -40.63% surge from the present price of $3.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.951 | $1.8805 | $2.3553 | -37.47% |
| February, 2026 | $2.0139 | $1.7128 | $2.3151 | -35.45% |
| March, 2026 | $1.9372 | $1.6724 | $2.2748 | -37.91% |
| April, 2026 | $1.8971 | $1.632 | $2.2346 | -39.20% |
| May, 2026 | $1.9142 | $1.5917 | $2.1943 | -38.65% |
| June, 2026 | $1.7513 | $1.5513 | $1.942 | -43.87% |
| July, 2026 | $1.7109 | $1.5109 | $2.154 | -45.16% |
| August, 2026 | $1.708 | $1.6375 | $2.1138 | -45.26% |
| September, 2026 | $1.6675 | $1.4705 | $2.0735 | -46.55% |
| October, 2026 | $1.7317 | $1.4301 | $2.0333 | -44.50% |
| November, 2026 | $1.6563 | $1.3898 | $1.993 | -46.91% |
| December, 2026 | $1.6161 | $1.3494 | $1.9528 | -48.20% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eupraxia Pharmaceuticals Inc (EPRX) is $1.429, with a high forecast of $1.9125 and a low forecast of $0.9456. This indicates an -54.20% decrease from the last price of $3.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6324 | $1.309 | $1.9125 | -47.68% |
| February, 2027 | $1.4686 | $1.2686 | $1.661 | -52.93% |
| March, 2027 | $1.4282 | $1.2282 | $1.8722 | -54.22% |
| April, 2027 | $1.4245 | $1.354 | $1.832 | -54.34% |
| May, 2027 | $1.4898 | $1.1879 | $1.7917 | -52.25% |
| June, 2027 | $1.4495 | $1.1475 | $1.7515 | -53.54% |
| July, 2027 | $1.3753 | $1.1071 | $1.7112 | -55.92% |
| August, 2027 | $1.3908 | $1.0667 | $1.6709 | -55.42% |
| September, 2027 | $1.3506 | $1.0263 | $1.6307 | -56.71% |
| October, 2027 | $1.186 | $0.986 | $1.38 | -61.99% |
| November, 2027 | $1.1815 | $1.111 | $1.5904 | -62.13% |
| December, 2027 | $1.141 | $0.9456 | $1.5502 | -63.43% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2028
In 2028, Eupraxia Pharmaceuticals Inc (EPRX) is projected to reach an average price of $1.0057, with a high projection of $1.5099 and a low estimate of $0.5014. This indicates an -67.77% fall from the last price of $3.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.2076 | $0.9052 | $1.5099 | -61.30% |
| February, 2028 | $1.1345 | $0.8648 | $1.4696 | -63.64% |
| March, 2028 | $1.0943 | $0.8244 | $1.4294 | -64.93% |
| April, 2028 | $1.109 | $0.7841 | $1.3891 | -64.45% |
| May, 2028 | $1.0688 | $0.7437 | $1.3489 | -65.74% |
| June, 2028 | $0.9033 | $0.7033 | $1.0991 | -71.05% |
| July, 2028 | $0.898 | $0.8275 | $1.3086 | -71.22% |
| August, 2028 | $0.8575 | $0.6629 | $1.2684 | -72.52% |
| September, 2028 | $0.9253 | $0.6225 | $1.2281 | -70.34% |
| October, 2028 | $0.8535 | $0.5822 | $1.1878 | -72.64% |
| November, 2028 | $0.8134 | $0.5418 | $1.1476 | -73.93% |
| December, 2028 | $0.8272 | $0.5014 | $1.1073 | -73.49% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2029
The 2029 price forecast for Eupraxia Pharmaceuticals Inc Stock (EPRX) is $0.5823 on average, with a high prediction of $1.0671 and a low estimate of $0.0976. This represents an -81.34% decrease from the previous price of $3.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.787 | $0.461 | $1.0671 | -74.78% |
| February, 2029 | $0.6206 | $0.4206 | $0.8181 | -80.11% |
| March, 2029 | $0.6145 | $0.544 | $1.0268 | -80.30% |
| April, 2029 | $0.6834 | $0.3803 | $0.9865 | -78.10% |
| May, 2029 | $0.6431 | $0.3399 | $0.9463 | -79.39% |
| June, 2029 | $0.5725 | $0.2995 | $0.906 | -81.65% |
| July, 2029 | $0.5857 | $0.2591 | $0.8658 | -81.23% |
| August, 2029 | $0.5454 | $0.2188 | $0.8255 | -82.52% |
| September, 2029 | $0.3784 | $0.1784 | $0.5773 | -87.87% |
| October, 2029 | $0.338 | $0.138 | $0.7852 | -89.17% |
| November, 2029 | $0.331 | $0.2605 | $0.745 | -89.39% |
| December, 2029 | $0.4012 | $0.0976 | $0.7047 | -87.14% |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Price Forecast for 2030
Eupraxia Pharmaceuticals Inc Stock (EPRX) is expected to reach an average price of $0.3327 in 2030, with a high forecast of $0.6645 and a low forecast of $0.000876. This signifies an -89.34% decrease from the last price of $3.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3609 | $0.0572 | $0.6645 | -88.43% |
| February, 2030 | $0.2916 | $0.0169 | $0.6242 | -90.65% |
| March, 2030 | $0.3039 | $0.0235 | $0.584 | -90.26% |
| April, 2030 | $0.1361 | $0.0639 | $0.3364 | -95.64% |
| May, 2030 | $0.0957 | $0.058 | $0.5437 | -96.93% |
| June, 2030 | $0.088 | $0.0175 | $0.5034 | -97.18% |
| July, 2030 | $0.0475 | $0.023 | $0.4632 | -98.48% |
| August, 2030 | $0.2119 | $0.000876 | $0.4229 | -93.21% |
| September, 2030 | $0.0507 | $0.00266 | $0.3827 | -98.37% |
| October, 2030 | $0.0106 | $0.00118 | $0.3424 | -99.66% |
| November, 2030 | $0.022 | $0.0412 | $0.3021 | -99.29% |
| December, 2030 | $0.1466 | $0.0812 | $0.0712 | -95.30% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):